ixigo Partners with Uber and redBus to Offer Integrated Cab and Bus Booking for Train Passengers Trump JrBacked Enhanced Games Steroid Olympics to Debut in Las Vegas Amid Controversy Indias REITs Expand Beyond Office Spaces Offering Retail Investors a Stable Income Avenue Wall Street Divided on Paramount Skydance Outlook Amid Industry Uncertainty Music Catalogs Attract Institutional Capital as SonyGIC Joint Venture Acquires Recognition Music Group for 4 Billion Delays and Border Check Suspension at Dover Disrupt Holiday Travel Impacting Ferry Operators and Tourism Sector BEKE Q4 2025 Earnings EPS Falls Short as Housing Market Headwinds Persist JBSS Q1 2026 Earnings EPS Surprises to the Upside Beating Estimates by Over 21 GXAI Q1 2026 Earnings EPS Misses Estimates No Revenue Reported CRVS Q1 2026 Earnings EPS Slightly Misses Estimates Amid Continued Clinical Development SKIN Q1 2026 Earnings EPS Beats Estimates Amid NarrowerThanExpected Loss AMSF Q1 2026 Earnings EPS Misses Estimates Amid Underwriting Pressure Genius Sports GENI Edges Higher as Stock Holds Above Key Support Perspective Therapeutics CATX Gains 284 as Stock Nears Key Resistance at 418 Velocity Financial VEL Consolidates Near 1743 as Traders Eye Support and Resistance Levels DCOMG Holds Steady at 2585 as FixedtoFloating Note Trades Between Key Levels CS Disco Inc LAW Edges Lower as Shares Test Key Support Levels US Stocks Surge on Report of USIran Deal Pending Trumps Approval GASS Q4 2025 Earnings EPS Beat of 417 Highlights Operational Efficiency Amid Market Headwinds Tuniu TOUR Pulls Back Sharply Testing Key Support Levels CATO Q4 2025 Earnings Negative EPS of 055 as Stock Gains 356 Amid Retail Headwinds SFIX Q1 2026 Earnings EPS Beats Expectations Amid Narrowed Loss Stock Slightly Down CTRI Q1 2026 Earnings EPS Surprises Positively Despite Loss Stock Declines STRW Q1 2026 Earnings EPS Beats Estimates by Nearly 15 CRVL Q1 2026 Earnings EPS of 061 Reported Stock Declines 285 TBRG Q1 2026 Earnings EPS Misses Street Estimate but Stock Edges Up CRNX Q1 2026 Earnings EPS Surprise Beats Estimates as PreRevenue Biotech Advances Pipeline